BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 11702600)

  • 1. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 2. MDS and secondary AML: an evolutionary perspective.
    Audeh MW
    Cancer Treat Res; 2001; 108():267-78. PubMed ID: 11702604
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.
    Padua RA; McGlynn A; McGlynn H
    Cancer Treat Res; 2001; 108():111-57. PubMed ID: 11702597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
    [No Abstract]   [Full Text] [Related]  

  • 6. Culture studies in vitro in human leukemia.
    Spitzer G; Verma DS; Dicke KA; McCredie KB
    Semin Hematol; 1978 Oct; 15(4):352-78. PubMed ID: 366760
    [No Abstract]   [Full Text] [Related]  

  • 7. Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
    Fassas AB; Tricot G
    Cancer Treat Res; 2001; 108():169-84. PubMed ID: 11702599
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular bases of myelodysplastic syndromes: lessons from animal models.
    Komeno Y; Kitaura J; Kitamura T
    J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preleukemia. Cytogenetic clues in some confusing disorders.
    Nowell PC
    Am J Pathol; 1977 Nov; 89(2):459-76. PubMed ID: 335894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cells (third of three parts).
    Quesenberry P; Levitt L
    N Engl J Med; 1979 Oct; 301(16):868-72. PubMed ID: 384249
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of hemopoietic stem cells and progenitor cells in preleukemia].
    Dörmer P; Mergenthaler HG
    Verh Dtsch Ges Pathol; 1990; 74():65-74. PubMed ID: 1708637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndromes: mechanisms of transformation and neoplastic progression and their clinical implications].
    Cazzola M; Bergamaschi G; Bolis C; Ponchio L; Rosti V; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():75-84. PubMed ID: 1752545
    [No Abstract]   [Full Text] [Related]  

  • 14. MDS-like experimental myelodysplasia: multilineage abnormal hematopoiesis in transgenic mice harboring the SV40 large T antigen under an immunoglobulin enhancer.
    Furuta Y; Aizawa S; Suda Y; Ikawa Y; Nishikawa S; Hayashi S; Hirabayashi Y; Inoue T
    Exp Hematol; 1993 Jun; 21(6):806-15. PubMed ID: 8500578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation.
    Sevilla J; Rodríguez A; Hernández-Maraver D; de Bustos G; Aguado J; Ojeda E; Arrieta R; Hernández-Navarro F
    Ann Hematol; 2002 Jan; 81(1):11-5. PubMed ID: 11807629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.
    Omidvar N; Kogan S; Beurlet S; le Pogam C; Janin A; West R; Noguera ME; Reboul M; Soulie A; Leboeuf C; Setterblad N; Felsher D; Lagasse E; Mohamedali A; Thomas NS; Fenaux P; Fontenay M; Pla M; Mufti GJ; Weissman I; Chomienne C; Padua RA
    Cancer Res; 2007 Dec; 67(24):11657-67. PubMed ID: 18089795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
    Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preleukemic states: an experimental murine model for myelodysplastic human syndromes].
    Defresne MP
    Bull Mem Acad R Med Belg; 2001; 156(1-2):99-104; discussion 105-6. PubMed ID: 11697189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndromes: preleukemic syndromes].
    Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.